Joseph Boyd Martin, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neurology | 6 | 2020 | 779 | 1.610 |
Why?
|
| Neurosciences | 3 | 2020 | 353 | 0.860 |
Why?
|
| Research Support as Topic | 4 | 2011 | 699 | 0.770 |
Why?
|
| Psychiatry | 3 | 2020 | 1686 | 0.700 |
Why?
|
| Conflict of Interest | 4 | 2010 | 549 | 0.560 |
Why?
|
| Industry | 3 | 2002 | 361 | 0.500 |
Why?
|
| Interinstitutional Relations | 3 | 2002 | 238 | 0.400 |
Why?
|
| Life | 1 | 2011 | 13 | 0.400 |
Why?
|
| Biomedical Research | 5 | 2015 | 3421 | 0.390 |
Why?
|
| Value of Life | 1 | 2011 | 98 | 0.380 |
Why?
|
| Work | 1 | 2011 | 194 | 0.360 |
Why?
|
| Drug Industry | 2 | 2006 | 789 | 0.210 |
Why?
|
| Efficiency, Organizational | 1 | 2006 | 697 | 0.200 |
Why?
|
| History, 20th Century | 5 | 2012 | 2777 | 0.190 |
Why?
|
| Technology Transfer | 3 | 2002 | 42 | 0.150 |
Why?
|
| Universities | 1 | 2002 | 983 | 0.140 |
Why?
|
| Complementary Therapies | 1 | 2001 | 487 | 0.140 |
Why?
|
| Nervous System Diseases | 1 | 2006 | 1647 | 0.130 |
Why?
|
| Financing, Government | 2 | 2011 | 472 | 0.120 |
Why?
|
| Academic Medical Centers | 4 | 2010 | 2753 | 0.120 |
Why?
|
| History, 19th Century | 3 | 2002 | 720 | 0.120 |
Why?
|
| Interdisciplinary Communication | 1 | 2020 | 934 | 0.120 |
Why?
|
| Schools, Medical | 1 | 2000 | 878 | 0.110 |
Why?
|
| History, 21st Century | 2 | 2012 | 1576 | 0.100 |
Why?
|
| Ohio | 1 | 2012 | 333 | 0.100 |
Why?
|
| History, 18th Century | 2 | 2001 | 207 | 0.090 |
Why?
|
| Median Eminence | 1 | 1990 | 28 | 0.090 |
Why?
|
| Neurodegenerative Diseases | 1 | 1999 | 1083 | 0.090 |
Why?
|
| Sex Differentiation | 1 | 1990 | 73 | 0.090 |
Why?
|
| Growth Hormone-Releasing Hormone | 1 | 1990 | 128 | 0.080 |
Why?
|
| Somatostatin | 1 | 1990 | 447 | 0.070 |
Why?
|
| Biomedical Technology | 1 | 2010 | 211 | 0.070 |
Why?
|
| Prolactin | 1 | 1990 | 621 | 0.070 |
Why?
|
| Growth Hormone | 1 | 1990 | 568 | 0.070 |
Why?
|
| Huntington Disease | 2 | 1999 | 1140 | 0.070 |
Why?
|
| Guidelines as Topic | 3 | 2002 | 1395 | 0.070 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2010 | 787 | 0.070 |
Why?
|
| Hospitals, Teaching | 1 | 2011 | 1166 | 0.070 |
Why?
|
| Forecasting | 1 | 2015 | 2931 | 0.060 |
Why?
|
| Professional-Patient Relations | 1 | 2011 | 725 | 0.060 |
Why?
|
| Research | 2 | 2006 | 1973 | 0.060 |
Why?
|
| Hypothalamus | 1 | 1990 | 998 | 0.060 |
Why?
|
| Access to Information | 1 | 2006 | 320 | 0.060 |
Why?
|
| Alzheimer Disease | 3 | 2015 | 8551 | 0.050 |
Why?
|
| Genetic Markers | 1 | 1988 | 2608 | 0.050 |
Why?
|
| Vasopressins | 1 | 1983 | 355 | 0.050 |
Why?
|
| Western World | 1 | 2001 | 26 | 0.050 |
Why?
|
| Pituitary Neoplasms | 1 | 1990 | 1313 | 0.050 |
Why?
|
| Ethics, Research | 1 | 2002 | 178 | 0.050 |
Why?
|
| Mental Processes | 1 | 2002 | 245 | 0.050 |
Why?
|
| Smallpox | 1 | 2000 | 43 | 0.050 |
Why?
|
| Humans | 15 | 2020 | 760261 | 0.040 |
Why?
|
| Endotoxins | 1 | 1983 | 521 | 0.040 |
Why?
|
| Systems Integration | 1 | 2002 | 426 | 0.040 |
Why?
|
| Internship and Residency | 1 | 2020 | 5867 | 0.040 |
Why?
|
| Spinocerebellar Degenerations | 1 | 1999 | 44 | 0.040 |
Why?
|
| United States | 5 | 2011 | 72363 | 0.040 |
Why?
|
| Tourette Syndrome | 1 | 2002 | 394 | 0.040 |
Why?
|
| Friedreich Ataxia | 1 | 1999 | 77 | 0.040 |
Why?
|
| Health Promotion | 1 | 2011 | 2208 | 0.040 |
Why?
|
| Trinucleotide Repeats | 1 | 1999 | 257 | 0.040 |
Why?
|
| Organizational Policy | 1 | 2000 | 429 | 0.040 |
Why?
|
| Neuromuscular Diseases | 1 | 1999 | 256 | 0.030 |
Why?
|
| Disclosure | 1 | 2002 | 738 | 0.030 |
Why?
|
| Fever | 1 | 1983 | 1618 | 0.030 |
Why?
|
| Mutation | 1 | 1999 | 29950 | 0.030 |
Why?
|
| Cooperative Behavior | 1 | 2002 | 1500 | 0.030 |
Why?
|
| Rats, Inbred WF | 1 | 1990 | 138 | 0.020 |
Why?
|
| Patient-Centered Care | 1 | 2000 | 1416 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2002 | 3561 | 0.020 |
Why?
|
| Education, Medical | 1 | 2000 | 1728 | 0.020 |
Why?
|
| Vaccination | 1 | 2000 | 3360 | 0.020 |
Why?
|
| Methods | 1 | 1988 | 1075 | 0.020 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1988 | 761 | 0.020 |
Why?
|
| Gene Expression | 1 | 1999 | 7592 | 0.020 |
Why?
|
| Feedback | 1 | 1990 | 791 | 0.020 |
Why?
|
| Amyloid beta-Peptides | 1 | 1999 | 3839 | 0.020 |
Why?
|
| Models, Biological | 1 | 2002 | 9468 | 0.020 |
Why?
|
| Brain | 2 | 2002 | 26912 | 0.020 |
Why?
|
| Parkinson Disease | 1 | 1999 | 2853 | 0.020 |
Why?
|
| Genetic Linkage | 1 | 1988 | 2381 | 0.010 |
Why?
|
| Massachusetts | 1 | 2015 | 8805 | 0.010 |
Why?
|
| Body Temperature Regulation | 1 | 1983 | 286 | 0.010 |
Why?
|
| Rats | 2 | 1990 | 23695 | 0.010 |
Why?
|
| Animals | 3 | 2006 | 167940 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2015 | 8058 | 0.010 |
Why?
|
| Biology | 1 | 2000 | 289 | 0.010 |
Why?
|
| Science | 1 | 2000 | 240 | 0.010 |
Why?
|
| Specialization | 1 | 2000 | 779 | 0.010 |
Why?
|
| Diffusion of Innovation | 1 | 2000 | 730 | 0.010 |
Why?
|
| Disease | 1 | 2000 | 671 | 0.010 |
Why?
|
| Mentors | 1 | 2000 | 662 | 0.010 |
Why?
|
| Antibodies | 1 | 1983 | 2424 | 0.010 |
Why?
|
| Faculty, Medical | 1 | 2002 | 1192 | 0.010 |
Why?
|
| Program Development | 1 | 2000 | 1297 | 0.010 |
Why?
|
| DNA | 1 | 1988 | 7236 | 0.010 |
Why?
|
| Teaching | 1 | 2000 | 1167 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1983 | 8157 | 0.010 |
Why?
|
| Patient Participation | 1 | 2000 | 1437 | 0.010 |
Why?
|
| Escherichia coli | 1 | 1983 | 4223 | 0.010 |
Why?
|
| Education, Medical, Graduate | 1 | 2000 | 2359 | 0.000 |
Why?
|
| Physician-Patient Relations | 1 | 2000 | 3242 | 0.000 |
Why?
|
| Curriculum | 1 | 2000 | 3722 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 1988 | 39254 | 0.000 |
Why?
|
| Male | 3 | 1990 | 359413 | 0.000 |
Why?
|
| Clinical Competence | 1 | 2000 | 4786 | 0.000 |
Why?
|
| Female | 2 | 1990 | 391011 | 0.000 |
Why?
|
| Middle Aged | 1 | 1988 | 220175 | 0.000 |
Why?
|
| Adult | 1 | 1988 | 219847 | 0.000 |
Why?
|